Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1955 1
1958 2
1959 1
1960 1
1961 2
1962 1
1963 1
1964 2
1966 1
1968 1
1970 1
1971 2
1973 2
1975 1
1977 3
1978 2
1981 2
1982 2
1984 3
1985 1
1986 1
1987 2
1988 7
1989 6
1990 6
1991 9
1992 3
1993 10
1994 4
1995 4
1996 5
1997 5
1998 4
2000 7
2001 9
2002 7
2003 8
2004 9
2005 6
2006 9
2007 13
2008 8
2009 15
2010 16
2011 17
2012 17
2013 20
2014 25
2015 17
2016 24
2017 22
2018 18
2019 29
2020 37
2021 36
2022 25
2023 35
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

494 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lorusso D, Xiang Y, Hasegawa K, Scambia G, Leiva M, Ramos-Elias P, Acevedo A, Sukhin V, Cloven N, Pereira de Santana Gomes AJ, Contreras Mejía F, Reiss A, Ayhan A, Lee JY, Saevets V, Zagouri F, Gilbert L, Sehouli J, Tharavichitkul E, Lindemann K, Lazzari R, Chang CL, Lampé R, Zhu H, Oaknin A, Christiaens M, Polterauer S, Usami T, Li K, Yamada K, Toker S, Keefe SM, Pignata S, Duska LR; ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators. Lorusso D, et al. Among authors: acevedo a. Lancet. 2024 Apr 6;403(10434):1341-1350. doi: 10.1016/S0140-6736(24)00317-9. Epub 2024 Mar 20. Lancet. 2024. PMID: 38521086 Clinical Trial.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Ready NE, Audigier-Valette C, Goldman JW, Felip E, Ciuleanu TE, Rosario García Campelo M, Jao K, Barlesi F, Bordenave S, Rijavec E, Urban L, Aucoin JS, Zannori C, Vermaelen K, Arén Frontera O, Curioni Fontecedro A, Sánchez-Gastaldo A, Juan-Vidal O, Linardou H, Poddubskaya E, Spigel DR, Ahmed S, Maio M, Li S, Chang H, Fiore J, Acevedo A, Paz-Ares L. Ready NE, et al. Among authors: acevedo a. J Immunother Cancer. 2023 Feb;11(2):e006127. doi: 10.1136/jitc-2022-006127. J Immunother Cancer. 2023. PMID: 36725084 Free PMC article. Clinical Trial.
Syndromes with gingival fibromatosis: A systematic review.
Costa CRR, Braz SV, de Toledo IP, Martelli-Júnior H, Mazzeu JF, Guerra ENS, Coletta RD, Acevedo AC. Costa CRR, et al. Among authors: acevedo ac. Oral Dis. 2021 May;27(4):881-893. doi: 10.1111/odi.13369. Epub 2020 May 25. Oral Dis. 2021. PMID: 32335995 Review.
Dental mineralization.
Goldberg M, Septier D, Lécolle S, Chardin H, Quintana MA, Acevedo AC, Gafni G, Dillouya D, Vermelin L, Thonemann B, et al. Goldberg M, et al. Among authors: acevedo ac. Int J Dev Biol. 1995 Feb;39(1):93-110. Int J Dev Biol. 1995. PMID: 7626424 Free article. Review.
An RNA-based system to study hepatitis B virus replication and evaluate antivirals.
Yu Y, Schneider WM, Kass MA, Michailidis E, Acevedo A, Pamplona Mosimann AL, Bordignon J, Koenig A, Livingston CM, van Gijzel H, Ni Y, Ambrose PM, Freije CA, Zhang M, Zou C, Kabbani M, Quirk C, Jahan C, Wu X, Urban S, You S, Shlomai A, de Jong YP, Rice CM. Yu Y, et al. Among authors: acevedo a. Sci Adv. 2023 Apr 14;9(15):eadg6265. doi: 10.1126/sciadv.adg6265. Epub 2023 Apr 12. Sci Adv. 2023. PMID: 37043562 Free PMC article.
Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta.
Yamaguti PM, de La Dure-Molla M, Monnot S, Cardozo-Amaya YJ, Baujat G, Michot C, Fournier BPJ, Riou MC, Caldas Rosa ECC, Soares de Lima Y, Dos Santos PAC, Alcaraz G, Guerra ENS, Castro LC, de Oliveira SF, Pogue R, Berdal A, de Paula LM, Mazzeu JF, Cormier-Daire V, Acevedo AC. Yamaguti PM, et al. Among authors: acevedo ac. J Dent Res. 2023 Jun;102(6):616-625. doi: 10.1177/00220345231154569. Epub 2023 Mar 23. J Dent Res. 2023. PMID: 36951356
The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis.
Acevedo A, Jones AE, Danna BT, Turner R, Montales KP, Benincá C, Reue K, Shirihai OS, Stiles L, Wallace M, Wang Y, Bertholet AM, Divakaruni AS. Acevedo A, et al. bioRxiv [Preprint]. 2023 Aug 16:2023.08.15.553413. doi: 10.1101/2023.08.15.553413. bioRxiv. 2023. Update in: J Biol Chem. 2024 Mar;300(3):105702. doi: 10.1016/j.jbc.2024.105702. PMID: 37645724 Free PMC article. Updated. Preprint.
494 results